Pi-cardia
Rehovot, N/A
Works in Cardiovascular
Pi-cardia is a clinical trial sponsor based in Rehovot, N/A. It has 1 active clinical trial with 150 planned participants, in Cardiovascular. Since 2021 it has completed 2 trials and stopped 3 early. Its FDA record on file shows 1 recall.
Trial track record · since 2021
FDA record
Recent FDA actions
Pipeline · 1 active trial
| Stage | Trial | Status |
|---|---|---|
Questions about Pi-cardia
No warning letter naming Pi-cardia is on file. FDA has published 1 recall naming it.
Yes. FDA's enforcement reports list 1 recall by Pi-cardia; the latest, reported on 2026-09-23, is a Class II recall.
Pi-cardia is lead sponsor of 1 active clinical trial on ClinicalTrials.gov, with 150 planned participants, in Cardiovascular. Since 2021 it has completed 2 trials and stopped 3 early.
Pi-cardia is based in Rehovot, N/A. The address is the one on its FDA records or ClinicalTrials.gov registrations, which name the establishment or the registrant, not always the group's head office.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with Pi-cardia; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-06-12.
The FDA record counts inspection classifications, warning letters and recalls FDA has published that name this company. Compare it with the industry in the free CDMO FDA inspection lookup.
Approve Suite is not affiliated with Pi-cardia.
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.